PC
GDRX icon

Pier Capital’s GoodRx Holdings GDRX Stock Holding History

Pier Capital’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-469,547
Closed -$3.26M – 131
2024
Q3 		$3.26M Buy
+469,547
New +$3.69M 0.46% 96
2020
Q4 		– Sell
-5,947
Closed -$331K – 120
2020
Q3 		$331K Buy
+5,947
New +$315K 0.05% 107

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RRCP
Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Pier Capital's GDRX Position: Q4 2024 in Review

Pier Capital sold out of GoodRx Holdings (GDRX) in Q4 2024, closing a stake of 469,547 shares — an estimated $3.26M sold.

Pier Capital first reported a position in GDRX in Q3 2020 and held it in 2 quarters. The position peaked at $3.26M in Q3 2024. 170 funds tracked by Wall St. Rank hold GDRX as of Q4 2024.

  • Pier Capital reported no remaining GoodRx Holdings position as of Q4 2024 after selling out during the quarter.
  • Pier Capital sold 469,547 GoodRx Holdings shares in Q4 2024, an estimated $3.26M.
  • Pier Capital first reported a position in GoodRx Holdings in Q3 2020 and held it in 2 quarters.
  • Pier Capital's GoodRx Holdings position peaked at $3.26M in Q3 2024.
  • 170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2024.

Based on Pier Capital's 13F filing for Q4 2024, filed 11 Feb 2025.